Historical salary details - Dr. Marc Rubin,M.D., Independent Director, Galectin Therapeutics Inc
Dr. Marc Rubin,M.D. is the Independent Director of Galectin Therapeutics Inc. They also hold 1 other positions in and Curis Inc.
Dr. Marc Rubin,M.D.
Independent Director
-
Gross Remuneration
-
Current Company
Galectin Therapeutics Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Galectin Therapeutics Inc | Independent Director | - | - |
| 2024 | Curis Inc | Independent Director | - | - |
| 2023 | Curis Inc | Independent Director | 123.7 K | -58.4 % |
| 2023 | Galectin Therapeutics Inc | Independent Director | 75.2 K | -22.8 % |
| 2022 | Curis Inc | Independent Director | 297.3 K | -5.6 % |
| 2022 | Galectin Therapeutics Inc | Independent Director | 97.4 K | -53.7 % |
| 2022 | Titan Pharmaceuticals, Inc. (de) | Director | - | - |
| 2021 | Curis Inc | Independent Director | 315.0 K | 67.6 % |
| 2021 | Galectin Therapeutics Inc | Independent Director | 210.3 K | 101.2 % |
| 2021 | Titan Pharmaceuticals, Inc. (de) | Executive Chairman of the Board, Principal Financi | - | - |
| 2020 | Curis Inc | Independent Director | 188.0 K | -11.3 % |
| 2020 | Galectin Therapeutics Inc | Independent Director | 104.5 K | -22.2 % |
| 2020 | Titan Pharmaceuticals, Inc. (de) | Executive Chairman of the Board, Principal Financi | - | - |
| 2019 | Curis Inc | Independent Director | 212.0 K | 2.1 % |
| 2019 | Galectin Therapeutics Inc | Independent Director | 134.3 K | 164.0 % |
| 2019 | Titan Pharmaceuticals, Inc. (de) | Executive Chairman of the Board and Principal Exec | - | - |
| 2018 | Curis Inc | Independent Director | 207.7 K | -16.2 % |
| 2018 | Galectin Therapeutics Inc | Independent Director | 50.9 K | -77.2 % |
| 2018 | Titan Pharmaceuticals, Inc. (de) | Executive Chairman of the Board | - | - |
| 2017 | Curis Inc | Independent Director | 247.9 K | 95.9 % |
| 2017 | Galectin Therapeutics Inc | Chairman of the Board | 223.4 K | 101.7 % |
| 2017 | Titan Pharmaceuticals, Inc. (de) | Executive Chairman of the Board | - | - |
| 2016 | Curis Inc | Independent Director | 126.6 K | 63.9 % |
| 2016 | Galectin Therapeutics Inc | Chairman of the Board | 110.7 K | 25.4 % |
| 2016 | Titan Pharmaceuticals, Inc. (de) | Executive Chairman of the Board | - | - |
| 2015 | Galectin Therapeutics Inc | Chairman of the Board | 88.3 K | - |
| 2015 | Curis Inc | Independent Director | 77.2 K | -8.2 % |
| 2015 | Titan Pharmaceuticals, Inc. (de) | Executive Chairman of the Board | - | - |
| 2014 | Curis Inc | Independent Director | 84.1 K | -2.9 % |
| 2014 | Galectin Therapeutics Inc | Independent Director | - | - |
| 2014 | Titan Pharmaceuticals, Inc. (de) | Executive Chairman of the Board | - | - |
| 2013 | Curis Inc | Independent Director | 86.6 K | -50.9 % |
| 2013 | Galectin Therapeutics Inc | Independent Director | 51.8 K | 331.4 % |
| 2013 | Titan Pharmaceuticals, Inc. (de) | Executive Chairman of the Board | - | - |
| 2012 | Curis Inc | Independent Director | 176.3 K | 171.6 % |
| 2012 | Galectin Therapeutics Inc | Independent Director | 12 K | -85.6 % |
| 2012 | Titan Pharmaceuticals, Inc. (de) | Executive Chairman of the Board | - | - |
| 2011 | Galectin Therapeutics Inc | Independent Director | 83.5 K | - |
| 2011 | Curis Inc | Independent Director | 64.9 K | -4.2 % |
| 2011 | Titan Pharmaceuticals, Inc. (de) | Executive Chairman of the Board | - | - |
| 2010 | Curis Inc | Independent Director | 67.8 K | - |
| 2010 | Titan Pharmaceuticals, Inc. (de) | Executive Chairman of the Board | - | - |
| 2009 | Titan Pharmaceuticals, Inc. (de) | Executive Chairman of the Board | - | - |